Bird & Bird has advised Proteome Sciences plc. Proteome Sciences plc, a UK-based company specialising in applied proteomics and peptidomics, has successfully completed a placing, subscription,...
Proteome Sciences Concludes £840,000 Fundraise Through Placing, Subscription, and Retail Offer
Cheyne Capital and Champneys Acquire Buxton Hotels
Bird & Bird has advised Cheyne Capital and Champneys. Cheyne Capital, a global alternative investment fund manager, in partnership with Champneys, has completed the acquisition of...
Faron Pharmaceuticals Ltd’s €30.7 Million Fundraising
Bird & Bird has advised Peel Hunt LLP. Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON) has completed a secondary fundraising led by London-based investment bank,...
Green Transition plc’s £6.46 Million IPO on AIM
Bird & Bird advised Panmure Gordon as Nominated Adviser, Sole Bookrunner and Broker on the deal. European Green Transition plc completed the listing and the IPO...